Dianthus Therapeutics (DNTH) Capital Expenditures (2017 - 2025)
Dianthus Therapeutics (DNTH) recorded Capital Expenditures of $5,000 in Q3 2025, down 80.0% from $25,000 a year earlier and down 89.1% from the prior quarter.
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Capital Expenditures (2017 - 2025) Analysis & Trends
On a TTM basis, Dianthus Therapeutics' Capital Expenditures came in at $106,000 as of Sep 30, 2025, up 26.2% year-over-year; for FY2024, it was $105,000, down 4.5% from FY2023.
- Annual Capital Expenditures has declined for three straight years, with a five-year compound annual growth rate of -49.1% (FY2019 to FY2024).
- Across earlier years, Capital Expenditures came in at $110,000 in FY2023 (-20.9%), $139,000 in FY2022 (-89.0%), $1.26 million in FY2021 (+216.0%) and $400,000 in FY2020 (-86.9%).
- The Q3 2025 figure is the lowest quarterly Capital Expenditures since Q3 2022.
- On a year-over-year basis, Capital Expenditures rose in three of the last eight quarters, with growth averaging 32.3%.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 285.7% in Q1 2022, against a decline of 94.7% in Q1 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $46,000 (Q2 2025), $24,000 (Q1 2025) and $31,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Dianthus Therapeutics | 3.76 Bn | 3.71 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 10,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 29,000.00 |
| Sep 30, 2022 | -46,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | 27,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 1.13 Mn |
| Jun 30, 2021 | 111,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | 213,000.00 |
API Access
Dianthus Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DNTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "DNTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=DNTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();